ZIMMER BIOMET HOLDINGS, INC. Repayments of Long-Term Debt
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Repayments of Long-Term Debt of $425.00 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-05.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2019-08-05
- ZIMMER BIOMET HOLDINGS, INC. repayments of long-term debt for the quarter ending 2019-06-30 was $115.00M.
- ZIMMER BIOMET HOLDINGS, INC. repayments of long-term debt for the quarter ending 2019-03-31 was $310.00M, a 37.78% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. repayments of long-term debt for the quarter ending 2018-12-31 was $925.00M, a 208.33% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. repayments of long-term debt for the quarter ending 2018-09-30 was $275.00M, a 43.88% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. repayments of long-term debt for fiscal 2018 was $1.43B, a 51.60% increase from fiscal 2017.
- ZIMMER BIOMET HOLDINGS, INC. repayments of long-term debt for fiscal 2017 was $940.00M, a 17.50% increase from fiscal 2016.
- ZIMMER BIOMET HOLDINGS, INC. repayments of long-term debt for fiscal 2016 was $800.00M, a 60.00% increase from fiscal 2015.
- ZIMMER BIOMET HOLDINGS, INC. repayments of long-term debt for fiscal 2015 was $500.00M.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2019-06-30 | $115.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $425.00M 10-Q · filed 2019-08-05 | $1.35B derived: sum of 3 quarters · filed 2019-08-05 | $1.63B derived: sum of 4 quarters · filed 2019-08-05 |
| 2019-03-31 | $310.00M 10-Q · filed 2019-05-06 | $1.24B derived: sum of 2 quarters · filed 2019-05-06 | $1.51B derived: sum of 3 quarters · filed 2019-05-06 | $1.51B derived: sum of 4 quarters · filed 2019-08-05 |
| 2018-12-31 | $925.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $1.20B derived: sum of 2 quarters · filed 2019-02-26 | $1.20B derived: sum of 3 quarters · filed 2019-08-05 | $1.43B 10-K · filed 2019-02-26 |
| 2018-09-30 | $275.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $275.00M derived: sum of 2 quarters · filed 2019-08-05 | $500.00M 10-Q · filed 2018-11-01 | $800.00M derived: sum of 4 quarters · filed 2019-08-05 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $225.00M 10-Q · filed 2019-08-05 | $525.00M derived: sum of 3 quarters · filed 2019-08-05 | $1.01B derived: sum of 4 quarters · filed 2019-08-05 |
| 2018-03-31 | $225.00M 10-Q · filed 2019-05-06 | $525.00M derived: sum of 2 quarters · filed 2019-05-06 | $1.01B derived: sum of 3 quarters · filed 2019-05-06 | $1.01B derived: sum of 4 quarters · filed 2019-05-06 |
| 2017-12-31 | $300.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $790.00M derived: sum of 2 quarters · filed 2019-02-26 | $790.00M derived: sum of 3 quarters · filed 2019-02-26 | $940.00M 10-K · filed 2019-02-26 |
| 2017-09-30 | $490.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $490.00M derived: sum of 2 quarters · filed 2018-11-01 | $640.00M 10-Q · filed 2018-11-01 | $740.00M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $150.00M 10-Q · filed 2018-08-06 | $250.00M derived: sum of 3 quarters · filed 2019-02-26 | $450.00M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $150.00M 10-Q · filed 2018-05-08 | $250.00M derived: sum of 2 quarters · filed 2019-02-26 | $450.00M derived: sum of 3 quarters · filed 2019-02-26 | $550.00M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $100.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $300.00M derived: sum of 2 quarters · filed 2019-02-26 | $400.00M derived: sum of 3 quarters · filed 2019-02-26 | $800.00M 10-K · filed 2019-02-26 |
| 2016-09-30 | $200.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $300.00M derived: sum of 2 quarters · filed 2017-11-06 | $700.00M 10-Q · filed 2017-11-06 | $1.05B derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $100.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $500.00M 10-Q · filed 2017-08-08 | $850.00M derived: sum of 3 quarters · filed 2018-02-27 | |
| 2016-03-31 | $400.00M 10-Q · filed 2017-05-09 | $750.00M derived: sum of 2 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $350.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $500.00M 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $150.00M 10-Q · filed 2016-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |